Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2016-12-29

FDA Approved: GLIPIZIDE — Original Application (Rising Pharma Holdings, Inc.)

View source ↗

Summary

The FDA approved Rising Pharma Holdings, Inc.'s original application for a generic version of glipizide to treat type 2 diabetes mellitus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Glipizide (Glipizide)

Snippet

ORIG AP for GLIPIZIDE (GLIPIZIDE)